2023-04-03 01:09:23 ET
- Emmaus Life Sciences press release ( OTCQX:EMMA ): FY GAAP EPS of -$0.21.
- Revenue of $18.39M (-10.8% Y/Y).
For further details see:
Emmaus Life Sciences GAAP EPS of -$0.21, revenue of $18.39M2023-04-03 01:09:23 ET
For further details see:
Emmaus Life Sciences GAAP EPS of -$0.21, revenue of $18.39MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Emmaus Life Sciences Incorporation Company Name:
EMMA Stock Symbol:
Market:
Emmaus Life Sciences Reports Delayed Filing of Annual Report PR Newswire TORRANCE, Calif. , April 15, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA) , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disea...
China Resources Beer (Holdings) Company Limited ADR (CRHKY) is expected to report for Q4 2023 Melco International Development Ltd. (MDEVF) is expected to report for quarter end 2023-12-31 Meridian Mining UK Societas (MRRDF) is expected to report $0 for Q4 2023 BKF Capital Group Inc (B...
The Dow Jones index closed higher by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern aroun...